Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
Jennifer T Leahy1, Catherine J Chu-Shore1,2, Janet L Fisher3 1Massachusetts General Hospital, Department of Neurology, Programs in Neurophysiology and Epilepsy, Boston, MA, 2Harvard Medical School, Boston, MA, 3University of South Carolina School of Medicine, Department of Pharmacology, Physiology a...
Guardado en:
Autores principales: | Leahy JT, Chu-Shore CJ, Fisher JL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2746b29c57814b9d8801f6779cc0802c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
por: Jessica Gresham, et al.
Publicado: (2010) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura G, et al.
Publicado: (2020) -
Treatment of Lennox-Gastaut syndrome: overview and recent findings
por: Kenou van Rijckevorsel
Publicado: (2008) -
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
por: Carl E Stafstrom
Publicado: (2009) -
Rufinamide in patients with Lennox-Gastaut syndrome
por: Clark PO, et al.
Publicado: (2016)